Related Experiment Video
Updated: Apr 12, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
[A roadmap toward total elimination of cancer]
Abstract:
Cancer stem cells (CSCs) were first experimentally identified in leukemia in 1997, and following researches demonstrated the existence of CSCs in a variety of solid cancers. It has been reported that CSCs are responsible for tumorigenicity, chemoresistance, and metastasis as well as heterogeneity of cancers. Therefore, elimination of CSCs may be crucial to eradicate cancer. Recent reports indicate that CSCs from some solid cancers show phenotypic plasticity, and intrinsic or extrinsic signals can revert differentiated cancer cells back into CSCs. These traits of CSCs may cause problems in devising targeted therapy against CSCs in future. Here we discuss how we can achieve total elimination of cancer cells in light of recent progress in understanding of CSCs.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Cancer
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...